Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 58, Issue 4, Pages 1424-1435
Publisher
Wiley
Online
2013-05-24
DOI
10.1002/hep.26520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats
- (2012) Eugenio Rosado et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
- (2012) Sabine Klein et al. JOURNAL OF HEPATOLOGY
- PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
- (2012) Aina Rodríguez-Vilarrupla et al. JOURNAL OF HEPATOLOGY
- Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
- (2012) Maeva Guillaume et al. JOURNAL OF HEPATOLOGY
- Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats
- (2011) J. P. De La Cruz et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis
- (2010) Paolo Gelosa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats
- (2010) Héctor García-Calderó et al. JOURNAL OF HEPATOLOGY
- Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
- (2010) J. N. FIESSINGER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis
- (2010) Aina Rodríguez-Vilarrupla et al. LIVER INTERNATIONAL
- Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: The role of Rho kinase
- (2009) Cui Qing Liu et al. BIOCHEMICAL PHARMACOLOGY
- TP Receptor Antagonism: A New Concept in Atherothrombosis and Stroke Prevention
- (2009) Angel Chamorro CEREBROVASCULAR DISEASES
- Thromboxane A2Receptor Activates a Rho-associated Kinase/LKB1/PTEN Pathway to Attenuate Endothelium Insulin Signaling
- (2009) Ping Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
- (2008) Marc Mejias et al. HEPATOLOGY
- Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
- (2008) Norimichi Nakahata PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now